Literature DB >> 19042030

The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder.

Robert Arbuckle1, Mark A Frye, Martin Brecher, Björn Paulsson, Kitty Rajagopalan, Susan Palmer, Alessio Degl' Innocenti.   

Abstract

Bipolar disorder (BD) adversely affects daily activities/functioning. The Sheehan Disability Scale (SDS) assesses disability in work/school activities, family relationships, and social functioning, and it evaluates the functional impact of psychiatric disorders. BD outpatients from 21 U.S. sites completed a battery of validated instruments (including the SDS) three times over 8-12 weeks. Instrument reliability (internal consistency, test-retest), validity (construct, convergent validity, known groups) and responsiveness were measured. There were missing data for the SDS in 2% of the 225 subjects with BD. One factor explained 82% of the variance. All SDS items had rotated factor loadings on the first factor >0.90, confirming the appropriateness of the SDS total score. Item-scale correlations surpassed 0.40. There was excellent internal consistency reliability for the SDS total score (Cronbach's alpha=0.89). Test-retest reliability was acceptable for the SDS total score (intraclass correlation coefficient=0.73). Correlations with other instruments demonstrate convergent and divergent validity. The SDS total and item scores significantly discriminated between (self-rated) overall health status, clinician-rated functional status, and clinician-rated depression, evidencing known group validity. The SDS demonstrated ability to detect change over time. The SDS is a valid, reliable measure of disability and is responsive to change over time when used in subjects with BD.

Entities:  

Mesh:

Year:  2008        PMID: 19042030     DOI: 10.1016/j.psychres.2007.11.018

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  39 in total

1.  Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial.

Authors:  Maja Sticker Nordbrandt; Charlotte Sonne; Erik Lykke Mortensen; Jessica Carlsson
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

2.  Race/Ethnicity and Treatment Outcome in a Randomized Controlled Trial for Trichotillomania (Hair-Pulling Disorder).

Authors:  Martha J Falkenstein; Kate Rogers; Elizabeth J Malloy; David A F Haaga
Journal:  J Clin Psychol       Date:  2015-04-01

Review 3.  Treatment of Functional Impairment in Patients with Bipolar Disorder.

Authors:  Jose Sanchez-Moreno; Anabel Martinez-Aran; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

4.  Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical Trial.

Authors:  Katherine E Watkins; Allison J Ober; Karen Lamp; Mimi Lind; Claude Setodji; Karen Chan Osilla; Sarah B Hunter; Colleen M McCullough; Kirsten Becker; Praise O Iyiewuare; Allison Diamant; Keith Heinzerling; Harold Alan Pincus
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

5.  The multimorbidity dead end: how we got here and possible ways out.

Authors:  Kevin Selby; Yolanda Mueller Chabloz; Joelle Schwarz; Nicolas Senn
Journal:  Br J Gen Pract       Date:  2020-11-26       Impact factor: 5.386

6.  Trajectories of maternal depression: a 27-year population-based prospective study.

Authors:  J M Najman; M Plotnikova; G M Williams; R Alati; A A Mamun; J Scott; N Wray; A M Clavarino
Journal:  Epidemiol Psychiatr Sci       Date:  2016-01-19       Impact factor: 6.892

7.  Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use.

Authors:  Kurt Kroenke; Xin Zhong; Dale Theobald; Jingwei Wu; Wanzhu Tu; Janet S Carpenter
Journal:  Arch Intern Med       Date:  2010-10-11

8.  CBT competence in novice therapists improves anxiety outcomes.

Authors:  Lily A Brown; Michelle G Craske; Daniel E Glenn; Murray B Stein; Greer Sullivan; Cathy Sherbourne; Alexander Bystritsky; Stacy S Welch; Laura Campbell-Sills; Ariel Lang; Peter Roy-Byrne; Raphael D Rose
Journal:  Depress Anxiety       Date:  2012-12-05       Impact factor: 6.505

9.  Self-awareness of functional impairment in individuals at clinical high-risk for psychosis.

Authors:  Doreen M Olvet; Ricardo E Carrión; Andrea M Auther; Barbara A Cornblatt
Journal:  Early Interv Psychiatry       Date:  2013-08-22       Impact factor: 2.732

10.  Predictors of treatment initiation for alcohol use disorders in primary care.

Authors:  Katherine E Watkins; Allison Ober; Colleen McCullough; Claude Setodji; Karen Lamp; Mimi Lind; Sarah B Hunter; Karen Chan Osilla
Journal:  Drug Alcohol Depend       Date:  2018-07-24       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.